Upper GI Bleeding Flashcards
Upper GI bleeding commonly presents with…
- Hematemesis
- Melena
Upper and lower GI bleeding defined based on their location relative to…
Ligament of Treitz
Obscure bleeding
Hemorrhage that persists or recurs after negative endoscopy (source not apparent)
Occult bleeding
Hidden bleeding found accidentally
Shock
Organs and tissues of the body not receiving adequate blood flow allowing for buildup of waste products
Hypovolemic shock
Hemorrhagic
Stage I (compensated) of shock
- Tachycardia
- Vasospasm
- Pt has few symptoms
- Tx can halt
Stage II shock
- Agitation, confusion, disorientation
- Myocardial ischemia (w or w/o chest pain)
- Decreased urine output
- Tx reverse
Stage III shock
- Heart fails
- Kidneys fail
- Circulatory collapse
- End-organ damage
- Death
Generalities of treating shock
- Rapidly diagnose the state of shock
- Diagnose the underlying condition
- Quickly intervene to halt the underlying condition
- Treat the effects of shock
- Support vital functions
Initial assessment
- ABCs (airway, breathing, circulation)
- Stable/unstable?
- Resuscitation
- Oxygen
- Trendelenburg position
- IV
- Blood transfusion
- Urgent surgical consultation
BUN:Creatinine ratio suggestive of upper GI bleed
> 36:1
Signs and symptoms of shock
- Systolic BP <100 mmHg
- Pulse >100/min
- Cool, clammy skin
- Prolonged capillary refill
- Changing mentation
- Complaints of syncope/near-syncope
- Decreased urine output
- Narrowed pulse pressure
- Hypotension
Positive orthostatics estimate how much loss of TBV
15-20%
Resting hypotension indicates how much loss of TBV
30-40%
ATLS guidelines for assessing shock patients
Any patient who is cool and tachycardic is in shock until proven otherwise
Risk factors for morbidity and mortality in acute GI hemorrhage
- Age >60 yr
- Comorbid disease (renal failure, liver disease, respiratory insufficiency, cardiac disease)
- magnitude of hemorrhage
- Persistent or recurrent hemorrhage
- Inpatient at time of bleed
- Severe coagulopathy
- Need for surgery
Proton pump inhibitors
- Start empirically prior to endoscopy
- High dose IV (pantoprazole, lansoprazole, esomeprazole)
- Can accelerate resolution of recent UGIB
- Can decrease length of hospital stay
- Significant reduction in risk of re-bleeding
- Improvement in mortality
PUD
- Duodenal or gastric
- Imbalance between protective mucosa and acid/pepsin
4 major risk factors for PUD
- H. pylori infection
- Use of NSAIDs
- Physiologic stress
- Excess gastric acid
Clinical features of PUD
- Epigastric pain
- Gastric ulcers (pain 5-15 minutes after eating, relieved by fasting, high risk of malignancy)
- Duodenal ulcers (pain 2-3 hours after eating, pain relieved temporarily by food, pain may wake at night, low risk of malignancy)
- Epigastric tenderness
Therapy for PUD
- EGD
- H2Blockers
- PPIs
- Sucralfate
Treatment of H. pylori
- Helidac therapy
- Prevpac therapy
Aspirin and NSAIDs and GI bleed
- Cause of both UGIB and LGIB
- NSAIDs and ASA inhibit cyclooxygenase mediated PGD synthesis so impairs mucosal protection
- High risk of bleeding in elderly w/o warning symptoms